Author

Kristy L. Berry

Auburn University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Adam B. KeetoniD· 1 shared Asfar Sohail AzmiiD· 1 shared Bassel F. El‐RayesiD· 1 shared Dhana Sekhar Reddy BandiiD· 1 shared Donald J. BuchsbaumiD· 1 shared Emily C. GraffiD· 1 shared Ganji Purnachandra NagarajuiD· 1 shared Gary Anthony PiazzaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam B. KeetonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal Adenocarcinoma

Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, Julienne L. Carstens, Jeremy B. Foote, Emily C. Graff, Yu-Hua Dean Fang, Adam B. Keeton, Xi Chen, Jacob Valiyaveettil, Kristy L. Berry, Sejong Bae, Mehmet Akce, Greg S. Gorman, Karina Jin Yoon, , Bassel F. El‐Rayes

ADT-1004, a pan-RAS inhibitor, shows strong antitumor activity in pancreatic ductal adenocarcinoma models with high selectivity and tolerable dosing.

Molecular Cancer · Mar 13, 2025Peer-reviewedCancer Biology